Skip to main content
. 2007 Feb 1;56(9):1335–1344. doi: 10.1007/s00262-007-0281-8

Table 2.

Pre-immunizations with VP2PyVLPs alone or loaded on DCs do not significantly reduce the anti-tumor effect of a subsequent Her21–68 3PyVLPs immunization

1st immunization 2nd immunization 3rd immunization Tumor takes a
DCs + VP2PyVLPs DCs + VP2PyVLPs Her21–683PyVLPs 7/10
– DCs + VP2PyVLPs Her21–683PyVLPs 5/10
VP2PyVLPs VP2PyVLPs Her21–683PyVLPs 7/10
– VP2PyVLPs Her21–683PyVLPs 4/10
– – Her21–683PyVLPs 4/10
– – – 10/10

aResults are reported as the number of tumor-positive animals per total number of animals challenged with D2F2/E2 cells